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Abstract 
Purpose: 
In this work, we present the analysis, design and optimization of one experimental device 
recently developed in the UK, called the 'GP' Thrombus Aspiration Device (GPTAD). This 
device has been designed to remove blood clots without the need to make contact with the 
clot itself thereby potentially reducing the risk of problems such as downstream embolisation. 
Method: 
To obtain the minimum pressure necessary to extract the clot and to optimize the device, we 
have simulated  the performance of the GPTAD analysing the resistances, compliances and 
inertances effects. We model a range of diameters for the GPTAD considering different 
forces of adhesion of the blood clot to the artery wall, and different lengths of blood clot. In 
each case we determine the optimum pressure required to extract the blood clot from the 
artery using the GPTAD, which is attached at its proximal end to a suction pump. 
Result: 
We then compare the results of our mathematical modelling to measurements made in 
laboratory using plastic tube models of arteries of comparable diameter. We use abattoir 
porcine blood clots that are extracted using the GPTAD. The suction pressures required for 
such clot extraction in the plastic tube models compare favourably with those predicted by the 
mathematical modelling. 
Discussion & Conclusion: 
We conclude therefore that the mathematical modelling is a useful technique in predicting the 
performance of the GPTAD and may potentially be used in optimising the design of the 
device.   
1 Introduction 
Stroke is one of the major causes of mortality in the 
world-wide. More than 120,000 strokes per year occur in 
the UK [1]. Six per cent of National Health Service and 
Social Services expenditure is spent on stroke 
management.  
Thrombosis is produced by the formation of a clot 
inside blood vessels causing an abrupt interruption of the 
blood flow [2]. In the cerebral arteries, this occlusion can 
result from the migration of a clot that has formed at 
another location. The process concerning the removal of 
this obstruction involves catheterisation [3]. 
Although thrombolytic agents such as Alteplase are 
used to dissolve such, there are limitations on their use. 
Consequently, alternative methods of treatment have 
been developed which includes Thrombectomy Devices. 
A number of Thrombectomy devices using a variety of 
methods have now been developed to facilitate clot 
removal. We present research involving one such 
experimental device recently developed in the UK, called 
a 'GP' Thrombus-Aspiration-Device (GPTAD) [4]. This 
device has the potential to bring about the extraction of a 
thrombus. Although the device is at a relatively early 
stage of development, the results look encouraging. 
The main objective of the work we present is to obtain 
the minimum pressure required to perform blood clot 
extraction and to check that this pressure as well as the 
time required to complete the clot extraction are 
reasonable for possible potential use on a patient and are 
similar to experimentally obtained data. In addition, we 
ascertain if the cerebral arteries are able to support the 
suction force to which they are subjected. We also 
determine that the components comprising the proposed 
device, based on the ‘GPTAD’ probe, and  the blood flow 
generate  speeds that fall within admissible parameters. 
We believe that such studies may help in optimising the 
design of the GPTAD and its possible future use in 
patients with thrombosis. 
 
This paper gives a brief description of the proposed 
device, based on the ‘GPTAD’ device, as well as the parts 
comprising it. The model used for the simulation is 
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described as well as the phenomena considered, and, in 
addition, the values of the parameters used are defined. 
Finally the results obtained and the conclusions of this 
study are described. 
2  ‘GP’ Thrombectomy Device 
A schematic view of the GPTAD is shown in figure 1. It 
has potential advantages in clot removal procedures in 
that it does not need to touch the clot to facilitate clot 
removal (therefore there is less risk of downstream 
embolisation), and it has no moving parts (therefore less 
risk of breaking). In vitro testing of the GPTAD to remove 
abattoir porcine blood clots in plastic tube models of 
arteries and modelling has been undertaken [5][6][7]. 
 
Fig. 1 Schematic diagram of the clot removal device. 
The GPTAD device assembly involves using a vacuum 
pump (that provides the suction pressure for removal of 
the clot), joined to a very long double lumen catheter 
(~100 cm long and ~2.0-5.0 mm in diameter); the ‘GP’ 
device is located at the end of this catheter (same 
diameter and a length of 20 mm). This GPTAD is 
introduced into the carotid artery via a transfemoral 
approach to the lower limb such that the GPTAD is 
positioned in close proximity to the occluding blood clot, 
at a distance of approximately 3 mm from it. Then the 
suction pressure is slowly increased until clot capture 
occurs and the clot is extracted. The clot crosses the 3 
mm “gap” (filled with blood) that separates it from the 
GPTAD and when clot capture occurs the entire device is 
then removed from the body.  
It is currently being developed as a potential thrombus 
aspiration device through a series of in-vitro studies. This 
device has the potential to be used in relatively small 
arteries too. It has no moving parts and therefore should 
reduce the risk of breakage in a vessel. Since it does not 
touch the clot itself it should also reduce the risk of clot 
disruption and downstream embolisation. Thrombectomy 
is achieved by aspiration through a catheter in which the 
‘GPTAD’ device is embedded. The internal surface has 
been mathematically optimized. It is also potentially 
associated with low forces at the periphery of the device 
which may therefore reduce the risk of arterial collapse 
during aspiration of the clot [8]. 
3 In-Vitro Experimental Considerations 
Clearly removal of arterial thrombus depends on 
several factors including the size of the clot, its location, 
and the force of attachment of the clot to the vessel wall. 
In designing any arterial clot removal device, many 
factors must be taken into account e.g. mechanical and 
biocompatibility factors relating to the biological tissue, 
also material strength and flexibility of the device. The risk 
of damaging or penetrating the vessel wall must also be 
considered, together with potential clot dislodgment then 
causing further distal damage. Taking into account these 
requirements, the blood clot removal device has been 
modelled using Bond graph modelling techniques. 
The design of the final device was the result of a series 
of modifications made from the original design, testing 
their efficacy in terms of their potential to remove jelly like 
clots. The main parameters measured each time were the 
time taken to remove the clot and the vacuum pressures 
required to remove the clots. 
Considering a simple case where a clot is located at 
one specific point on the vessel wall, it has been 
previously studied by Fung [9]. In this study, the occlusion 
of the artery is defined by the angle that the clot subtends 
in relation to the circumference of the artery. Rekhter [10] 
considered the effect of clots associated with 
atheromatous plaques and found values for the typical 
force with which an atheromatous plaque is attached to an 
artery wall. Dr. CJ Flannery [11] determined that a 
thrombus can be detached at a maximum upstream 
pressure of ~450 mmHg, which is six-tenths of an 
atmosphere, or roughly 4 times mean arterial blood 
pressure. The total thrombus detachment strength was 
calculated to be approximately 8.9 mN, i.e. thrombus 
removal from a stenosis was measured with a force of 
detachment being at the high end of about 9 mN. In all 
analysed cases by Dr. Flannery, thrombus adhesion 
strength was between 0.25 and 9 mN. This is consistent 
with the below in vitro measurements of glycoprotein 
surface density and adhesion strength found in literature 
review. From the previous values, in our work we will use 
10 mN. 
In vitro experiments were also undertaken to measure 
the forces (in kPa) required to remove the jelly, using the 
apparatus described in figure 2 below [12]. A vertical tube 
supplied with tap water at the lower inlet to create a water 
column is placed with its length of 0.5 metres to be 
accessed by the tap and the suction line. During 
suctioning the water level is kept constant by re-supplying 
water in the same amount as the suctioned volume. The 
required suction pressure at the suction line is supplied 
via a vacuum source. The vacuum source is an evacuated 
glass vessel (1 L) connected to a vacuum pump. Suction 
starts by opening a valve (clamp) in the suction line when 
the device is in place. In the shown case, an artificial clot 
was used to simulate the blood clot because it has similar 
mechanical properties and was readily available. 
 
 
Fig. 2 Apparatus used in the experiment. 
From the previous experiments, it was found that the 
force required to remove a jelly-like clot a few mm in 
diameter using a GP clot removal device (of internal 
diameter 3mm and external diameter 4mm and length 
10mm) was 10Kpa. The removal time for this jelly like clot 
was 15 seconds and the volume of fluid extracted in the 
process was 17 ml. These results (typically 15kPa) are in 
good agreement with the results obtained in the practical 
experiments quoted above (10kPa). 
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4 Modelling the GPTAD Device 
The main objective of this study is to introduce a model 
that can be used investigate and assist in the final design 
of the GPTAD. In this work we investigate the potential 
performance of the GPTAD device under different 
conditions of blood flow, size of blood clot, in a given 
vessel. 
The method chosen for the representation and 
simulation of the GPTAD in this instance is the Bond 
Graph technique [13-14-15], which allows assimilating the 
model to an electric circuit made up of inductances, 
capacitances and resistances. Therefore, it is possible to 
obtain the results in a simple way by evaluating flows and 
efforts that join and connect the components of the 
model. To obtain the simulation of the model, Bondin © 
software will be used [16]. This program allows us to 
obtaining the evolution of the characteristic parameters of 
the model as well as letting them be compared. 
To generate the correct model, it was necessary to 
analyze the inertances due to mass of fluid, the 
compressibility that the blood and artery are subjected  to, 
and finally the resistances that appear when fluid and 
blood clot flow into the catheter [17]. 
First the pump, which is the component that creates 
the necessary pressure to carry out the extraction, is 
positioned. It can be represented by a variable pressure 
source (Se) whose value will increase from zero to a non-
determined value suitable for carrying out this operation 
and will be obtained from the optimization of the 
developed model. The time taken to reach the maximum 
value of pressure has been obtained from experience and 
must be about 3 sec., after which time the pressure 
provided by the pump remains constant. 
 The pump links to the catheter, a 110 cm long 1 mm 
diameter hollow cylindrical tube which is joined to the 
‘GPTAD’ device of the same diameter and of length 20 
mm. In order to represent both elements, they are 
considered as several pipe sections bearing in mind the 
different phenomena that take place in their interior: load 
and inertia loss, and fluid compressibility [17]. 
Firstly, the flow inertia to be overcome in its movement 
is taken into account and considering a section with 
circular geometry it must be represented by a type ‘I‘ port 
and a type ‘1’ junction and can be modelled with this 
expression: 
 
( )2
2
D
L
I
×
×
=
p
r
 (1) 
 
where ‘r‘ is the blood density, ‘L’ the length of the pipe 
section and ‘D’ its diameter. 
The blood has been deemed to be an incompressible 
fluid and this eliminates the blood compressibility effect; if 
we wanted to take it into account, it should be included as  
a compliance that produces a decrease in volume when 
the pressure required for compression is increased. This 
behaviour would be dependent on the Bulk coefficient for  
blood, ‘B’ and it could be defined as a capacitance of 
value ‘K’. 
Due to the friction between the liquid particles and the 
pipe walls, load losses appear. Since we are dealing with 
straight pipes in our model, only linear load losses are 
taken into account. As the pipe is horizontal and of 
constant cross section in each section, the load loss is 
reduced, since there is a pressure loss as the fluid 
advances along the pipe, the loss being progressive and 
proportional to the length of the pipe. This pressure loss 
can be represented by a resistance and a type ‘1’ 
junction. If we assume that when artery is 100% occluded 
there is no flow, and since the Reynolds number is only 
significant if turbulent flow is involved, the equation that 
governs its behaviour can be determined by following 
expression (2), where ‘η‘ is the dynamic viscosity of the 
blood flow, ‘L’ the length of the pipe section and ‘D’ its 
diameter. 
  
(2)
 
 
The flow of blood may well be turbulent at an arterial 
bifurcation for example, or in the case of an atheromatous 
plaque associated with a pathological blood clot, not 
existent in this case. In these situations it would be 
necessary to determine the load losses for turbulent flow 
and taking into account Reynolds number. 
Following on from the tube corresponding with the 
catheter, the ‘GPTAD’ device (see figure 1) must be 
positioned such that it can be represented with its 
corresponding values. 
Due to the artery being located at the end of the 
‘GPTAD’ device, it is necessary to consider the transition 
between both elements as a secondary load loss caused 
by the difference in diameter of the ‘GPTAD’ probe and 
the artery respectively and the subsequent variations in 
flow (deflecting nozzle in figure 4). These load losses can 
be represented as a resistance and can be calculated with 
the following expression (3), where ‘r‘ is the blood density, 
‘Q’ is the flow which circulates in the section between the 
end of the ’GPTAD’ probe and the artery, and the 
diameter ‘D’ is the mean value between the probe (DGP) 
and the artery (Dartery). 
 
42 ·
···8
D
Q
R
p
xr=  (3) 
 
The load loss coefficient ‘ξ‘ is a dimensionless 
parameter that quantifies the loss produced and depends 
on the geometry of the conical aperture. 
 
Fig. 3 Load loos coefficient values. 
Considering the results obtained in figure 3, the ideal 
value for the design of the ‘GP’ diameter is that which 
corresponds with the same diameter that the artery, in 
which case it would create zero load loss. In patients it is 
not possible to use the exact value and considering it to 
be a narrowing with DGP = 1.5·Dartery, this value can be 
considered as being 0.3 in the best case.  
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=
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Fig. 4 Full model of the GPTAD 
 
 The artery can be included in the model as another 
section of a pipe, similar to the catheter and the ‘GPTAD’ 
device and it must be defined by the loss of linear load ‘R’ 
and the inertia ‘I‘ (figure 4). In addition, it is necessary to 
insert a parameter that represents the compressibility of 
the artery, in line with its Young‘s modulus:   
  
 
00 ·2·
·
rV
hE
K =  (5) 
 
where ‘E’ is its Young’s modulus, ‘h’ is the thickness of 
the artery, ‘V0‘ is the artery initial volume and ‘r0‘ is the 
artery initial radius. According to Guthold et al. [18], fibrin 
fibres in the clot deform elastically, not plastically, and the 
Young's modulus of fibrin is about 1 MPa. 
Once the elements corresponding to pump, catheter, 
‘GPTAD’ device and artery have been defined by fluid 
mechanics, it is necessary to change from the domain of 
hydraulics to mechanics, to be able to evaluate the 
movements and efforts in clot removal, as well as to 
define the physical friction between the clot and the 
artery. This domain change is carried out by a 
Transformer (TF) element. To calculate the value of the 
coefficient defining this element, the change in the 
definition of the flow before and after this element is 
evaluated; it is known that there is no leakage around the 
clot and no blood gets past the clot when it is causing 
100% occlusion of an artery. The coefficient must be 
determined by evaluating the required change between 
both domains; before the TF element, the flow is in the 
hydraulics domain, while afterwards, it is in the 
mechanical domain. Then, the coefficient of the TF 
element must be the inverse of the section of artery.  
Whilst in the mechanical domain, in the model it is 
necessary to insert a compliance between the end of the 
artery and the beginning of the clot to obtain the force 
supported by the clot each moment; this force is 
necessary to begin or stop the movement of the blood clot 
in accordance with the minimum necessary pressures 
obtained in section 3. 
The friction between the clot and the arterial wall 
creates a resistance factor. The value of this parameter 
must be variable depending on whether the clot has 
begun its movement (dynamic friction) (3rd case in figure 
5) or before it has begun to move (static friction) (1st and 
2nd cases in figure 5) during the clot extraction procedure. 
 
 
Fig. 5 Influence of the suction force over blood clot 
When the clot begins to move the friction decreases 
considerably. This value is obtained from the Stokes 
equation and can be given a value of 2.5·10-6 N·s/m for 
the static friction and an order of magnitude lower than for 
the dynamic friction. The transition between both values 
marks the beginning or end of the clot movement. 
In addition to the compliance and the resistance 
inserted, the model must have an inertance that 
represents the mass of the clot (~0.05 - 3 gr.) (figure 5). 
Finally, to ensure that the clot remains at rest while the 
force existing at its beginning is less than 10 mN, a 
compliance-resistance system joined to a wall (zero flow 
source) must be used (figure 4). In this system, while the 
clot does not receive the force of minimum suction, it has 
zero speed. However, when it begins its movement, the 
compliance-resistance system must be cancelled allowing 
its extraction. 
Therefore, while the force representing the deformation 
of the clot is lower than 10 mN, it will remain attached to 
the wall (1st and 2nd cases in figure 5), thereby preventing 
any movement. To the contrary, if the force exceeds this 
value, the model will cause the bond imposed by the 
compliance-resistance system to be eliminated with the 
clot becoming free and moving in accordance with the 
suction pressure acting on it from the system, thus 
allowing it to be removed (3rd case in fig. 5). 
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5 Results 
The aim of this simulation is to compare the extraction 
of a clot in different arteries (5.5 mm, 3.2mm and 2.5 mm) 
considering different clot lengths (0.5 cm up to 5.0 cm 
each case) and 100% occlusion; in our case, 90% will be 
blood clot and 10% atheromatous plaque. An arterial 
occlusion of 90% will modify the area in which the suction 
force acts, considering that the clot reduces the cross-
sectional area of the artery. 
The use of arteries of different diameters will influence 
directly the diameters of GP device that can be used in a 
given artery and hence those used in our modelling 
presented here. In the previously arterial diameters, the 
standard elements (‘GP’ and catheter) would have 
normalized values; it being necessary to choose the 
nearest diameter value to be inserted into the artery (5.0 
mm, 3 mm and 2.0 mm respectively). 
The existence of different clot lengths will affect the 
mass of the clot being removed (0.06 gr. up to 3 gr.), and 
increase the time taken for clot removal as the value of 
the clot length increases. 
The following figures show the time taken to create the 
necessary suction force to move the clot across the 3 mm  
between the clot and ‘GP’ device, for different pump 
suction pressures, diameters and clot lengths. 
 
 
Fig. 6 Pressure (kPa) vs time (secs) 
The previous figure indicates the time needed to move 
the clot across the 3mm gap filled with blood, to enable 
clot capture to occur  for the case of a blood clot length 
5cm in length. We observe that there is a difference on 
applying vacuum suction in each artery. The time taken to 
remove the blood clot in each instance is also different for 
each case.  
There are clearly differences in the times taken to 
remove the blood clot of various different diameters. 
While for a pressure of -30 Kpa the required time is below 
7 seconds in all cases, the use of smaller suction 
pressures causes the range of times for clot removal to 
increase near to 1 minute in some cases, e.g. with -4kPa 
pressure. In some instances, lower pressure sometimes 
increases the required time to more than 10 minutes –
these cases correspond with the smaller arteries. It 
should be noted that the pressure losses are inversely 
related to the artery cross-section. It is possible to 
speculate that a minimum required suction pump 
pressure must be around -4 kPa or -6 kPa, and that the 
corresponding clot removal times would then take less 
than ¾ or ½ minute.  
In figure 7 results are shown for the different diameter 
arteries and with a -6 kPa pressure pump, for each length 
of clot, together with the time when the clot begins to 
move until and it reaches the end of the ‘GP’ device. In 
considering the results of the modelling presented in 
figure 7, it can be seen that clots with a length between 1 
cm to 2 cm, need relatively short times for clot capture (2-
12 secs.). However, clots with a size between 4 cm to 5 
cm show a bigger variation in the time involved with 
different diameters (12 secs up to 30 secs). 
 
 
Fig. 7 Length clots (cm) vs time (secs) 
Higher clot removal times result when the clot lengths 
are greater e.g. with a 5 cm clot length in the smallest 
arteries. 
These results indicate the importance of carrying out 
clot extraction as quickly as possible, and indicate the 
potential uses and importance of such modelling. 
6 Conclusions 
Analyzing the obtained results, they are coherent with 
the physic laws and, in addition, they are very similar to 
in-vitro experimentally obtained results by using the same 
values for each parameter. Actually, only few in-vitro 
experiments has been done taking into account porcine 
blood clots and the entire validation of the mathematical 
model should be done comparing new situations and 
experiments. After it, the developed model could be used 
correctly to optimise the final design of the device in terms 
of materials, roughness or diameters of catheter and GP. 
Nevertheless, the development of this simulation model 
enables us to obtain an estimate of the minimum pressure 
required to perform the extraction of blood clots of 
different sizes and for different diameters of arteries. In all 
cases we have taken the same age for the clot residing in 
the artery and the same values for the force of adhesion. 
This modelling has shown that the suction pressure 
together with the time required to complete clot removal 
are reasonable, and should be within acceptable clinical 
boundaries for any eventual potential use of the GPTAD 
device in patients. A similar analysis [19-20-21] 
undertaken for its use in the MCA or the Popliteal artery 
enables further comparisons to be made. We compare the 
results of simulation modelling to measurements made in 
laboratory plastic tube models of arteries of comparable 
diameter where the GPTAD was applied to successfully 
extract abattoir porcine blood clots. The suction pressures 
required for such clot extraction in these plastic tube 
models compare favourably with those predicted by the 
simulation modeling. Taking into account the comments 
done at the beginning of this section, the mathematical 
modelling presented may potentially be useful in 
predicting the performance of the GPTAD and could 
possibly be used in optimising the design of the device. 
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7 Future Works 
The presented mathematical modelling is now being 
implemented to model and simulate different adhesion 
forces and a range of percentage arterial occlusions. In 
this future modeling include the systolic/diastolic pressure 
effects for case of arterial occlusion below 100% 
(including clot and plaque). 
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